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Abstract
Objective To determine the bias associated with frequency of visits by
physicians in adjusting for illness, using diagnoses recorded in
administrative databases.
SettingClaims data from the USMedicare program for services provided
in 2007 among 306 US hospital referral regions.
Design Cross sectional analysis.
Participants 20% sample of fee for service Medicare beneficiaries
residing in the United States in 2007 (n=5 153 877).
Main outcome measures The effect of illness adjustment on regional
mortality and spending rates using standard and visit corrected illness
methods for adjustment. The standard method adjusts using comorbidity
measures based on diagnoses listed in administrative databases; the
modified method corrects these measures for the frequency of visits by
physicians. Three conventions for measuring comorbidity are used: the
Charlson comorbidity index, Iezzoni chronic conditions, and hierarchical
condition categories risk scores.
Results The visit corrected Charlson comorbidity index explained more
of the variation in age, sex, and race mortality across the 306 hospital
referral regions than did the standard index (R2=0.21 v 0.11, P<0.001)
and, compared with sex and race adjusted mortality, reduced regional
variation, whereas adjustment using the standard Charlson comorbidity
index increased it. Although visit corrected and age, sex, and race
adjusted mortality rates were similar in hospital referral regions with the
highest and lowest fifths of visits, adjustment using the standard index
resulted in a rate that was 18% lower in the highest fifth (46.4 v 56.3
deaths per 1000, P<0.001). Age, sex, and race adjusted spending as
well as visit corrected spending wasmore than 30% greater in the highest
fifth of visits than in the lowest fifth, but only 12% greater after adjustment
using the standard index. Similar results were obtained using the Iezzoni
and the hierarchical condition categories conventions for measuring
comorbidity.
Conclusion The rates of visits by physicians introduce substantial bias
when regional mortality and spending rates are adjusted for illness using
comorbidity measures based on the observed number of diagnoses
recorded in Medicare’s administrative database. Adjusting without
correction for regional variation in visit rates tends to make regions with
high rates of visits seem to have lower mortality and lower costs, and
vice versa. Visit corrected comorbidity measures better explain variation
in age, sex, and race mortality than observed measures, and reduce
observational intensity bias.
Introduction
Good methods of risk adjustment are essential to make sense
of observed regional variations in utilization, expenditure, and
mortality rates between healthcare regions. Unwarranted
variation in the use of resources and in outcomes can thus be
understood more precisely and the information targeted to
improve quality and respond to fiscal pressures. Studies over
three decades have shown that the key driver of regional
variations in per capita spending for hospitals across areas are
variations in admission rates (not in costs per case), and these
exceed what would be expected given known differences in
morbidity.1-5 These studies raise the question of the extent to
which variation in resource use and healthcare outcomes, after
the conventional adjustments in the United States for age, sex,
and race, are justified because of differences in risk. Although
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it is well recognized that data on utilization of healthcare cannot
be used directly as a sound proxy for risk, as these data also
reflect differences in access to supply of healthcare resources,6-9
methods of risk adjustment have been developed based on
diagnoses recorded in medical records and insurance claims.
Such methods are routinely used in calculating standardized
mortality rates in the public reporting of hospital mortality10-15
and in observational studies of the relation between healthcare
use and outcomes.16-19 They are also used to adjust for
comorbidity in making payments to physicians20 and to third
party payers: insurance companies in the Netherlands,21 the US
Medicare’s Advantage program,22 and the formula used to
determine target allocations of resources to clinical
commissioning groups in England.23
The validity of methods that use data on diagnoses to estimate
risk depends on the assumption that recorded diagnoses are
independent of supply, and hence closely reflect the true
underlying burden of illness; or that adequate controls have
been developed to control for the effects of supply. One study9
emphasized the importance of adequate controls in designing
methods of risk rating to counter incentives for “cream
skimming.” The assumption that diagnostic data do offer
objective measures of need is known to be suspect as differences
in coding practices have already been shown to introduce an
“up-coding” bias in comparing mortality across hospitals.24But
these studies did not consider the effects of differences in
intensity of patient observation. Recent studies that have done
so have demonstrated that the intensity of patient observation,
measured by the frequency of visits by physicians and the
number of laboratory tests and imaging exams is associated
with the frequency of diagnosis recorded in Medicare claims
data, independent of underlying illness, as measured bymortality
adjusted for age, sex, and race. In a natural experiment,Medicare
beneficiaries who migrated to regions with a higher intensity
of care (measured by spending on end of life care) experienced
more physician visits, diagnostic tests, and imaging exams and
accrued more comorbid diagnoses as measured by hierarchical
condition categories risk score than did those who migrated to
regions with a lower intensity of care, even though the mortality
rates over a three year follow-up period after migration were
similar.25 A second study showed that as the regional intensity
of patient observation increased (measured by the average
numbers of physician visits, different physicians seen, imaging
exams, and laboratory tests), the mean number of chronic
illnesses diagnosed using the Iezzoni convention for measuring
comorbidity also increased, even though the age, sex, and race
mortality rates among regions were similar.26
We examined the magnitude of the bias associated with the
intensity of patient observation using three conventions for
measuring comorbidity: the Charlson comorbidity index,27 the
Iezzoni chronic condition count,28 and the hierarchical condition
categories risk score.22 We compared two methods for risk
adjustment: the standard method, which adjusts for comorbidity
based on recorded diagnoses, and a modified method that
reduces the impact of supply by correcting comorbiditymeasures
to remove the component associated with intensity of patient
observation (visits by physicians). To make this correction we
used the rate of visits by a physician during the last six months
of a patient’s life, a measure of observational intensity that is
unrelated to disease burden as measured by age, sex, and race
adjusted mortality. We tested the validity of the two methods
by examining how well they explain and reduce regional
variation in age, sex, and race adjustedmortality and their effects
on illness adjusted mortality and price adjusted spending rates
in regions with high and low rates of physician visits.We discuss
the implications of our findings for the ways in which these
strategies are used for risk adjustment.
Methods
Conceptual framework
Figure 1⇓ illustrates our conceptual framework and study design.
We consider the observed number of different diagnoses to be
a product of two factors: the actual burden of disease (the true
or intrinsic amount of disease) and the intensity of observation
(which conditions the likelihood of having a diagnosis for a
given level of disease burden). Conceptually, the intensity of
observation represents the combined effect of a spectrum of
factors: the resolution of diagnostic exams (including the
physical exam, imaging, and laboratory exams), the thresholds
used to label exam results as abnormal, the frequencywith which
exams are done, and the number of observers who have an
opportunity to make a diagnosis.
The intensity of observation is related to the frequency of contact
with a physician: the number of visits by physicians, specialist
referrals, and admissions to hospital. For this analysis we made
use of our prior work29 and focused on the rate of physician
visits in the last six months of life as a proxy for intensity of
observation.We then used this proxy to produce a visit corrected
measure of illness—essentially subtracting out the intensity of
observation component from the observed Charlson comorbidity
index, the Iezzoni chronic illness count, and the hierarchical
condition categories risk score.
To test whether this new method is a better approximation of
actual disease burden, we compared observed comorbidity
measures with visit corrected comorbidity measures for their
ability to explain and reduce regional variation in the least
ambiguous measure of disease burden: age, sex, and race
adjusted mortality rates among the sampled Medicare
population. We then compared the effect of these two methods
of risk adjustment on mortality and spending in individual
hospital referral regions and in hospital referral regions
aggregated into fifths according to the frequency of physician
visits.
Data and measures
We obtained from the Centers of Medicare and Medicaid
Services the insurance claims for a 20% sample of Medicare
beneficiaries. We restricted the analysis to those beneficiaries
who were either fully enrolled in part A and part B of Medicare
throughout 2007 and were 65-99 years old on 31 December
2007 or fully enrolled beginning 1 January 2007 until their death
that year and were 65-99 years old at their time of death.
Because the claims data for beneficiaries enrolled in risk contract
health maintenance organizations were incomplete, they were
excluded. Analysis was also restricted to beneficiaries who were
resident in one of the 306 hospital referral regions as defined
in the Dartmouth Atlas of Health Care.29 (The hospital referral
regions were empirically defined based on patient origin studies
to define the geographic region served by tertiary hospitals.)
The sampled Medicare population in hospital referral regions
ranged from 2549 to 91 020 beneficiaries. The final sample,
covering all 306 hospital referral regions, totaled 5 153 877
beneficiaries.
Our proxy measures for the number of different diagnoses were
the illness measures used by each convention. The Charlson
comorbidity index27 comprises 19 acute and chronic conditions
with assigned risk scores calibrated to predict one year mortality.
The Iezzoni chronic condition28 is a count of up to 12 chronic
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conditions selected on ability to predict one year mortality. The
hierarchical condition categories risk score22 is a composite
measure based on an individual’s age, sex, and Medicaid and
disability status. It is based on the coding algorithms used by
Medicare to adjust payments for Medicare Advantage plans30;
it incorporates an array of diagnoses grouped according to the
hierarchical condition categories classification system—70
diagnostic groups calibrated to predict spending and also used
to adjust mortality rates for illness in public reporting of hospital
mortality.
For a beneficiary to be counted as having a condition, the
diagnosis had to be coded either on at least one hospital
discharge abstract after an inpatient stay or on at least two claims
involving physician contact that were at least seven days apart.
This was done to reduce the likelihood that a diagnosis was
recorded for a condition that was to be “ruled out” by further
study.
The proxy for intensity of observation was the frequency of
visits by physicians. To ensure that no direct relation could exist
between our proxy for intensity of observation and comorbidity
score or mortality we measured physician visits in the prior year
(2006). We have adapted this measure for the Dartmouth Atlas
of Health Care29 in our hospital referral regions, by reducing it
to the average of the total number of visits for evaluation and
management (both inpatient and outpatient) made by physicians
per beneficiary in the last six months of life, a subset of patient
records for which the severity of illness is unlikely to vary
importantly across regions. (The regional variation in visit rates
is not explained by differences in illness related factors such as
age, sex, race, poverty, or type of medical condition.)31
Visit corrected comorbidity score
We calculated a visit corrected measure of illness using simple
linear regression in which the dependent variable was the
observed illness measure (as calculated from the claims data)
and the independent variable was the measure of frequency of
visits by physicians. The dependent variable was an individual
person level comorbidity measure and the independent was the
physician visit rate at hospital referral region level. For example,
for the Charlson comorbidity index, the residual from this
regression—the difference between observed index and
predicted index based on the frequency of physician visits—is
the visit corrected index. In other words, the residual represents
the component of illness not explained by the frequency of
physician visits—that is, our proxy for the intensity of
observation. Comparable regression models were used to
generate person level visit corrected indices for both the
hierarchical condition categories risk score and the Iezzoni
chronic condition count.
Ability to explain and reduce regional
variation in age, sex, and race mortality
We then compared observed comorbidity with visit corrected
comorbidity for each of the three measurement conventions for
their ability to explain and reduce the regional variation in age,
sex, and race adjusted mortality for the sampled populations.
Regional adjusted mortality rates were calculated using a linear
regressionmodel at the patient level (SASGENMODprocedure)
with 20 age, sex, and race indicator variables, along with the
306 hospital referral regions included as classification variables,
and no intercept. We used the resulting region level coefficients
to construct age, sex, and race adjusted mortality rates. Regional
“standard method” illness adjusted rates were calculated by
adding the patient level illness measure (for example, Charlson
score) to the age, sex, and race regression model, using the
region level coefficients to construct the rates. We calculated
the regional “modified method” illness adjusted rates by adding
the patient level visit corrected comorbidity score to the age,
sex, and race regression model, again using the region level
coefficients to construct the rates.
The percentage of the variation in age, sex, and race adjusted
mortality explained by observed compared with visit adjusted
comorbidity was analyzed at the regional level using the
coefficient of determination (R2). Results are reported for
weighted as well as unweighted regressions for hospital referral
region sample size.Wemeasured the effect on regional variation
among the 306 hospital referral regions by using standard
statistics: ratio of highest to lowest hospital referral region; ratio
of 75th to 25th centile; and the coefficient of variation (standard
deviation divided by the mean, expressed as a percentage).
Effect of illness adjustment on mortality and
Medicare spending
Finally, we compared the effect of risk adjustment using
observed and visit corrected comorbidity measures on mortality
and price adjustedMedicare spending.32Adjustment of spending
according to age, sex, and race was accomplished using the
same methods as for mortality. The resulting hospital referral
region variable estimates represent direct adjusted hospital
referral region level mortality and spending rates. Similarly, we
also computed adjusted rates for hospital referral regions
aggregated into fifths based on the rates of visits by physicians.
A series of three regression models was run similar to the
regional models but incorporated the fifths as classification
variable instead of hospital referral regions.
Results
Observed comorbidity, physician visits, and
mortality
Among the 306 hospital referral regions, the mean number of
physician visits per decedent during the last six months of life
varied across the regions from 10 to 59 and was not correlated
with age, sex, and race adjusted mortality (R2=0.000, P=0.88).
The rate of visits, however, was strongly correlated with the
number of diagnoses observed in the claims data. The correlation
with the mean hierarchical condition categories score was
R2=0.53 (P<0.001) andwith themean number of Iezzoni chronic
conditions and Charlson comorbidity index was 0.46 (P<0.001)
each. This combination of findings suggests that the frequency
of physician visits serves as a good proxy for the intensity of
observation: associated with the frequency of diagnosis but not
confounded by the actual burden of disease.
Ability to explain and reduce variation in age,
sex, and race adjusted mortality
The ability of observed and visit corrected comorbiditymeasures
to explain the variation in age, sex, and race adjusted mortality
was shown using unweighted regressions (fig 2⇓). For the
hierarchical condition categories, the Iezzoni and the Charlson
conventions, comorbidity measures based on the diagnoses in
the claims data explained 10-12% of the variation in age, sex,
and race adjusted mortality among the 306 hospital referral
regions; however, when the observed comorbidity measures
were corrected for visits they explained 21-24% of the variation,
or about twice as much. Regressions weighted for the sample
size of the hospital referral regions explained less: 2-5% of the
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variation in age, sex, and race adjusted mortality using observed
comorbidity and 17-21% for visit corrected comorbidity.
Compared with age, sex, and race adjustedmortality, adjustment
using observed comorbidity resulted in an increase in regional
variation in mortality rates, whereas adjustments using visit
corrected comorbidity resulted in a decrease in variation for
each of the three conventions (fig 3⇓).
Effect of adjustment on hospital referral
region specific mortality
Table 1⇓ illustrates the effect of risk adjustment using the
Charlson comorbidity index on apparent mortality among
hospital referral regions aggregated into fifths based on rates of
visits by physicians. The rate of visits in the highest fifth was
2.4 times that of the lowest fifth. However, the age, sex, and
race adjusted mortality rates in these two fifths were similar
(51.0 v 50.0 per 1000). Adjustment for illness using the observed
Charlson comorbidity index had a strong impact on illness
adjusted mortality: it became highest in the lowest fifth for visits
and decreased in a stepwise fashion across fifths of increasing
visit rates. Compared with adjustment by age, sex, and race
alone, mortality increased by 10.3% in the lowest fifth of visits
and decreased by 7.1% in the highest fifth. Thus, after
adjustment using the observed Charlson comorbidity index, the
illness adjusted mortality rate in the highest fifth of visits was
17.6% lower than in the lowest fifth, despite a nearly identical
age, sex, and race adjusted mortality rate.
The effect on mortality of adjustment using the visit corrected
Charlson comorbidity index was different. Compared with age,
sex, and race adjusted mortality rates, the mortality rates among
the fifths showed little change; the stepwise inverse association
with rate of visits seen with adjustment using the observed index
disappeared; and there was little difference in mortality between
the highest and lowest fifths.
Table 1 also provides information on the effect of adjustment
for illness in six hospital referral regions with large urban
populations; three with high and three with low mean rates of
visits by physicians. Compared with adjustment for age, sex,
and race, adjustment using the observed Charlson comorbidity
index decreased mortality by 18.3% in Miami, 3.2% in Los
Angeles, and 13.3% in Manhattan; mortality rates in
Minneapolis, Seattle, and Salt Lake City increased by 23.5%,
15.1%, and 20.6%, respectively. Adjustment using visit
corrected Charlson comorbidity index resulted in less change
in each region except for Los Angeles.
Similar findings were seen for the fifths and the selected hospital
referral regions, when adjustments were made using Iezzoni
chronic conditions and hierarchical condition categories risk
scores (table 2⇓) For example, using the standard method, the
illness adjusted morality rate in the highest fifth of visits was
19.0% lower than in the lowest fifth using Iezzoni chronic
conditions and 21.8% lower using hierarchical condition
categories risk scores.
Effect of adjustment on hospital referral
region specific price adjusted spending
Age, sex, and race adjusted and price adjusted Medicare
spending in our 20% sample varied among regions, from $5323
(£3376; €3936) to $15 706 per beneficiary and, in contrast with
age, sex, and race mortality, was highly correlated with supply
as measured by physicians visit rates for end of life care
(R2=0.46). Table 3⇓ illustrates the effect of adjustment for illness
on Medicare spending using observed hierarchical condition
categories risk scores (the standard adjustment used by the
Medicare program to pay insurance companies) compared with
visit corrected risk scores. In the fifth with the highest rate of
visits, age, sex, and race-price adjusted spending was 32.4%
greater than in the lowest fifth. Adjusting for observed
hierarchical condition categories risk scores increased spending
by 12.8% in the lowest fifth of visits and decreased it by 8.3%
in the highest fifth of visits; as a result, illness adjusted spending
in the highest fifth was only 7.7% greater than in the lowest
fifth. Risk adjustment using visit corrected hierarchical condition
categories risk scores resulted in a much smaller change.
Table 3 also illustrates the impact of adjustment on the selected
hospital referral regions. Based on age, sex, and race-price
adjustment alone, the mean Medicare spending per beneficiary
inMiami, Los Angeles, andManhattan was substantially greater
than in Minneapolis, Seattle, and Salt Lake City. After
adjustment for illness using observed hierarchical condition
categories risk scores, spending in Manhattan was less than in
Minneapolis, Seattle, and Salt Lake City; and spending in
Minneapolis and Salt Lake City was more than in Los Angeles.
Adjustment using visit corrected hierarchical condition
categories score resulted in important less change in spending
in each region.
Similar findings were obtained for fifths and the selected
hospital referral regions using the Charlson comorbidity index
and Iezzoni chronic conditions (table 4⇓).
Data for each hospital referral region for visit rates and effects
of adjustment on age, sex, and race mortality and price adjusted
spending can be downloaded from the Dartmouth atlas website
(www.dartmouthatlas.org/).
Discussion
Methods of risk adjustment lack face validity if they fail to
reduce variation and result in implausible changes in age, sex,
and race mortality rates. The standard method of illness
adjustment based on observed comorbidity measures obtained
fromMedicare’s administrative databases explained little of the
variation in underlying disease burden as measured by age, sex,
and race adjusted mortality and increased rather than decreased
regional variation. Moreover, it resulted in implausible changes
in mortality rates in regions with high and low rates of visits by
physicians. Although age, sex, and race adjusted mortality rates
were virtually the same in the highest and lowest fifths of visits,
the standard method resulted in illness adjusted mortality that
was 18% lower in the highest fifth of visits using the Charlson
comorbidity index, 19% lower using Iezzoni chronic conditions,
and 22% lower using hierarchical condition categories risk
scores.
The visit corrected method for illness adjustment proved to be
a better predictor of the underlying burden of illness. For each
convention for defining comorbidity, the visit corrected method
explained much more of the variation in age, sex, and race
adjusted mortality; it reduced rather than increased regional
variation compared with the standard method of adjustment and
did not result in unlikely changes in illness adjusted mortality
rates in regions with high and low rates of visits by physicians.
Limitations of the study
Our analysis has several limitations. Firstly, it was restricted to
fee for service Medicare and thus captures only part of the
experience of the insured population. Since our data did not
include Medicare Advantage (Medicare’s capitated insurance
plan), we were unable to examine the association between
financial incentives involving capitation and the number of
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;346:f549 doi: 10.1136/bmj.f549 (Published 21 February 2013) Page 4 of 11
RESEARCH
diagnoses nor evaluate the impact of Medicare’s policy to use
hierarchical condition categories risk scores to reduce “cream
skimming” by health insurance companies serving patients
enrolled inMedicare Advantage. Secondly, our analysis cannot
distinguish between the intensity of observation and intentional
up-coding. Coding practices could vary among regions and are
not addressed by the risk adjustment methods discussed here.
However, to the extent that such behavior was correlated with
frequency of visits by physicians, it would be controlled for by
our adjustment method. Thirdly, although we use physician
visits during the last six months of life as a proxy for intensity
of patient observation, the results are not sensitive to this
measure: Among the 306 hospital referral regions, the rates of
visits in 2006 for those alive at the end of the year were highly
correlated with visits for those who died and, like the end of
life visit rate, were not correlated with age, sex, and race
adjusted mortality rates. Using visit rates in 2006 for those alive
at the end of 2006 to adjust hierarchical condition categories
scores gave results similar to those reported here. Fourthly, the
method for correcting for observational intensity using visit
rates as a proxy depends on the availability of this information
in administrative databases, limiting the applicability of the
method elsewhere. Fifthly, our method for counting diagnoses
excludes likely rule-out diagnoses and is thus more conservative
than the method used by the Centers for Medicare & Medicaid
Services in adjusting Medicare Advantage payments, which
counts such diagnoses. In a sensitivity analysis, we found that
including rule-out diagnoses in calculating risk scores resulted
in even greater changes from age, sex, and race adjusted
mortality and spending, particularly in regions at the extreme
high and low end of the spectrum of variation in rates of
physician visits. Finally, this study did not evaluate risk
adjustment methods that, in addition to comorbidity measures
based on administrative databases, incorporated measures of
supply23 or prior healthcare use.33 Further research would be
needed to evaluate the ability of such methods to reduce the
observational intensity bias observed when risk adjustment is
based on counts of diagnoses recorded in claims data.
Our study emphasizes the importance of recognizing the
differences between data generated in different ways, as Taleb
argued.34 Those that are produced socially are problematic to
interpret because they have meaning to those that generate them
and tend to have highly skewed distributions. Those that are
produced naturally are straightforward to interpret and tend to
follow Gaussian distributions. It is thus a serious categorical
error to treat the former data like the latter. In healthcare this
distinction has also to be made between social data, such as per
capita supply of medical expenditure, admission rates, physician
visits, and medical diagnoses; and biologic data, such as height
and mortality, which tend to follow a Gaussian distribution.
Adjustment methods that depend on the number of different
diagnoses recorded in medical records and administrative
databases are subject to observational bias rooted in the varying
capacity of the local healthcare system: the more physicians
involved in care, the more visits, the more diagnostic tests, the
more imaging exams, and the more diagnoses and comorbidities
uncovered and recorded in the claims data. Adjustment
methodologies that assume that a diagnosis made in Miami,
Manhattan, or Los Angeles contains the same information as
one made in Minneapolis, Seattle, or Salt Lake City are guilty
of what one author labeled the constant risk fallacy: the
assumption that the underlying relations between case mix
variables and outcomes are constant across populations or over
time.35 In their study of bias in the Dr Foster Unit’s standardized
mortality ratios, Mohammed et al36 illustrate this phenomenon
by documenting inconsistency in the relation between the
Charlson comorbidity index and adjusted mortality rates across
four UK hospitals. For the same methodological reasons this
work identifies the same problem on an international scale and
offers a plausible reason that can be corrected through a less
biased case mix adjustment.
In short, the more one looks, the more one finds. This means
that using data on diagnoses to adjust for risk produces potential
problems in three areas:
Bias in research and evaluation—Observational studies that
use case mix adjustments based on claims data are suspect. For
example, if, as for Medicare, spending or utilization per capita
and rates of diagnosis are highly correlated, then research that
seeks to evaluate the relation between use of medical care and
mortality while controlling for illness using recorded diagnoses
will produce biased estimates.30-32
Biased performance measures—Adjusting performance
measures using several different diagnoses makes providers
who frequently make diagnoses look better than those who
manage their patients more conservatively. Thus, as in the Dr
Foster Unit example, adjusting quality and efficiency measures
for observed number of diagnoses appears to distort rather than
improve the reliability of performance measures. The use of
these adjustment methods in public reporting of hospital
mortality is widespread, including England,10 the United
States,11 12 Canada,13 the Netherlands,14 and Sweden.15
Biased payment to third party payers—Adjusting payments to
third party payers on the basis of the frequency of diagnoses
recorded in administrative databases may result in higher per
capita payments in regions with more physicians, hospital beds,
and visits per capita, independent of underlying disease burden.
This problem has long been recognized in designing methods
of risk adjustment to counter the tendency to avoid sicker
patients in order to improve apparent outcomes and profitability,
the so called “cream skimming” 9 Hence, methods of risk
adjustment that use data of diagnoses try to control for the
effects of supply by including socioeconomic data, and data on
supply and utilization by individuals. The question raised by
the evidence reported here is to what extent is a given method
susceptible to observational intensity bias?
Conclusions
We have shown that a method of risk adjustment that used data
on diagnoses and controlled for the effects of supply, by using
data on the frequency of visits by physicians in the year prior
to a patient’s death, wasmore efficient than the standardmethod;
but that still accounted for less than 25% of geographic variation
in age, sex, and race adjusted mortality among fee for service
Medicare beneficiaries. Thus, our study points to the importance
of developing risk adjustment methods that better explain
variation in age, sex, and race mortality rates and suggests that
these will be found by using data that are clearly independent
of the effects of supply.
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What is already known on this topic
Among US regions, a strong association exists between the mean number of diagnoses in Medicare’s database for insurance claims
and the intensity of patient observation measured by physician visits per capita
However, rates of visits by physicians are not correlated with age, sex, and race adjusted mortality
Illness adjustment methods that use the number of diagnoses recorded in administrative databases may be biased by the intensity of
observation
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was about 20% lower than the regions in the lowest fifth (observational intensity bias)
When the usual Medicare risk adjustment method was corrected to remove the effect of visits, the mortality rates were similar in all fifths
The visit corrected method better explained and reduced variation among regions in burden of illness measured by age, sex, and race
mortality and resulted in plausible mortality and spending rates in regions with high and low visit rates
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Tables
Table 1| Effect on apparent mortality of standard and visit corrected methods of adjustment for illness using Charlson comorbidity index
Visit corrected Charlson comorbidity
indexStandard Charlson comorbidity indexASR adjusted
mortality:
deaths/1000 (95%CI)Visits/decedentVariables
% change from
ASR adjustmentDeaths/1000 (95% CI)
% change from
ASR adjustmentDeaths/1000 (95% CI)
Visit fifth*:
3.152.6 (52.2 to 53.0)10.356.3 (55.9 to 56.7)51.0 (50.6 to 51.4)18.01st (lowest)
−1.653.1 (52.7 to 53.5)1.754.9 (54.5 to 55.3)54.0 (53.6 to 54.4)23.62nd
−1.952.1 (51.7 to 52.5)−0.652.8 (52.4 to 53.2)53.1 (52.7 to 53.6)26.83rd
−2.651.7 (51.3 to 52.2)−4.151.0 (50.6 to 51.4)53.1 (52.7 to 53.5)31.24th
3.251.5 (51.1 to 51.9)−7.146.4 (46.0 to 46.8)50.0 (49.5 to 50.4)43.95th (highest)
0.980.820.982.44Ratio (high-low)
Selected regions:
10.053.9 (51.3 to 56.6)20.659.1 (56.5 to 61.7)49.0 (46.3 to 51.8)13.7Salt Lake City
7.553.3 (51.3 to 55.3)15.157.1 (55.1 to 59.1)49.6 (47.5 to 51.7)17.9Seattle
16.750.6 (48.6 to 52.6)23.553.6 (51.6 to 55.6)43.4 (41.3 to 45.5)20.3Minneapolis
−2.745.1 (43.4 to 46.7)−13.340.2 (38.5 to 41.8)46.3 (44.6 to 48.0)43.2Manhattan
16.355.0 (53.7 to 56.4)−3.245.8 (44.4 to 47.2)47.3 (45.9 to 48.8)55.9Los Angeles
1.252.2 (50.0 to 54.5)−18.342.2 (39.9 to 44.4)51.6 (49.3 to 53.9)58.3Miami
ASR=age, sex, and race.
*Data are for 306 hospital referral regions aggregated into fifths according to mean number of visits by physicians in last six months of life for deaths in 2006.
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Table 2| Effect on apparent mortality of standard and visit corrected methods of adjustment for illness using Iezzoni chronic conditions
and hierarchical condition categories (HCC) risk scores
Visit corrected HCC risk scoresStandard HCC risk scores
Visit corrected Iezzoni chronic
conditions
Standard Iezzoni chronic
conditions
Variables
% change
from ASR
adjustment
Deaths/1000 (95%
CI)
% change
from ASR
adjustment
Deaths/1000 (95%
CI)
% change
from ASR
adjustment
Deaths/1000 (95%
CI)
% change
from ASR
adjustment
Deaths/1000 (95%
CI)
Visit fifth*:
1.551.8 (51.4 to 52.2)12.157.2 (56.8 to 57.6)2.852.4 (52.0 to 52.8)10.556.4 (56.0-56.8)1st (lowest)
−2.552.6 (52.2 to 53.0)2.455.3 (54.9 to 55.6)−1.653.1 (52.7 to 53.5)2.055.0 (54.6 to 55.4)2nd
−2.052.1 (51.7 to 52.5)−0.153.1 (52.7 to 53.5)−1.552.3 (51.9 to 52.8)−0.153.1 (52.7 to 53.5)3rd
−1.452.4 (52.0 to 52.8)−3.651.2 (50.8 to 51.6)−2.052.1 (51.7 to 52.5)−3.651.2 (50.8 to 51.6)4th
4.552.2 (51.8 to 52.6)-10.544.7 (44.3 to 45.1)2.551.2 (50.8 to 51.6)−8.645.7 (45.3 to 46.1)5th (highest)
1.010.780.980.81Ratio
(high-low)
Selected
regions:
5.651.8 (49.2 to 54.3)21.059.3 (56.8 to 61.9)6.752.3 (49.7 to 55.0)18.157.9 (55.2 to 60.7)Salt Lake
City
4.651.9 (49.9 to 53.9)15.857.4 (55.5 to 59.4)8.353.7 (51.7 to 55.8)16.557.8 (55.7 to 59.8)Seattle
17.951.1 (49.2 to 53.1)27.855.4 (53.5 to 57.4)18.951.6 (49.5 to 53.6)26.154.7 (52.7 to 56.7)Minneapolis
−8.742.3 (40.7 to 43.9)−24.135.1 (33.5 to 36.7)−8.442.4 (40.8 to 44.1)−19.837.2 (35.5 to 38.8)Manhattan
8.451.3 (50.0 to 52.6)−20.237.8 (36.5 to 39.1)16.855.3 (53.9 to 56.7)−4.245.4 (44.0 to 46.7)Los Angeles
−8.247.3 (45.2 to 49.5)−36.732.6 (30.5 to 34.8)−4.449.3 (47.1 to 51.6)−25.338.5 (36.3 to 40.8)Miami
*Data are for 306 hospital referral regions aggregated into quintiles according to mean number of physician visits last 6 months of life for deaths in 2006.
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Table 3| Effect on apparent price adjusted Medicare spending of standard and visit corrected methods of adjustment for illness using
hierarchical condition categories (HCC) risk scores
Illness adjustedAge, sex, and race
adjusted
Visits/
decedent
Variables
Visit corrected HCC risk scoresStandard HCC risk scores
spending/person
(95% CI) % change from
ASR adjustment
Spending/person(95%
CI)
% change from
ASR adjustment
Spending/person (95%
CI)
Visit fifth*:
1.67342 (7318 to 7366)12.88153 (8129 to 8177)7228 (7195 to 7262)18.01st (lowest)
−2.48027 (8003 to 8051)2.38419 (8395 to 8443)8227 (8193 to 8260)23.62nd
−1.98337 (8314 to 8361)−0.18492 (8468 to 8516)8498 (8464 to 8531)26.83rd
−1.38767 (8743 to 8791)−3.28595 (8571 to 8619)8878 (8844 to 8912)31.24th
3.59910 (9886 to 9933)−8.38782 (8759 to 8805)9572 (9539 to 9605)43.95th (highest)
1.351.081.322.44Ratio (high-low)
Selected regions:
5.57808 (7655 to 7961)20.98944 (8791 to 9097)7399 (7184 to 7615)13.7Salt Lake City
5.27022 (6904 to 7141)17.57848 (7729 to 7966)6677 (6511 to 6844)17.9Seattle
16.68149 (8032 to 8266)25.88792 (8675 to 8909)6986 (6822 to 7150)20.3Minneapolis
−6.58699 (8603 to 8795)−18.07624 (7528 to 7720)9300 (9165 to 9435)43.2Manhattan
6.310 169 (10 089 to 10 249)−14.98141 (8061 to 8221)9571 (9459 to 9683)55.9Los Angeles
−4.115 070 (14 939 to 15 201)−18.112 866 (12 735 to 12 997)15 706 (15 522 to 15
891)
58.3Miami
*Data are for 306 hospital referral regions aggregated into fifths according to mean number of visits by physicians in last six months of life for deaths in 2006.
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Table 4| Effect on apparent price adjusted Medicare spending of standard and visit corrected methods of adjustment for illness using
Charlson comorbidity index and Iezzoni chronic conditions
Visit corrected Iezzoni chronic
conditions
Standard Iezzoni chronic
conditions
Visit corrected Charlson
comorbidity index
Standard Charlson comorbidity
index
Variables
% change
from ASR
adjustment
Spending/person
(95% CI)
% change
from ASR
adjustment
Spending/person
(95% CI)
% Change
from ASR
adjustment
Spending/person
(95% CI)
% change
from ASR
adjustment
Spending/person
(95% CI)
Visit fifth*:
3.67489 (7460 to 7528)13.88226 (8179 to
8255)
3.47475 (7447 to 7503)11.48051 (8024 to
8079)
1st (lowest)
−1.98067 (8039 to 8096)2.48424 (8395 to
8453)
−1.78091 (8063 to 8118)1.78370 (8342 to
8397)
2nd
−1.88348 (8320 to 8377)−0.18489 (8460 to
8517)
−1.98339 (8311 to 8367)−0.68449 (8421 to
8476)
3rd
−2.28683 (8654 to 8712)−3.88527 (8498 to
8556)
−2.48663 (8635 to 8691)−3.88540 (8512 to
8568)
4th
2.49800 (9772 to 9828)−8.38775 (8747 to
8803)
2.69819 (9792 to 9846)−5.89017 (8990 to
9044)
5th (highest)
1.311.071.311.12Ratio
(high-low)
Selected
regions:
8.38011 (7826 to 8197)22.29046 (8860 to
9231)
10.48166 (7988 to 8344)21.38974 (8796 to
9152)
Salt Lake
City
11.57442 (7299 to 7585)22.78194 (8050 to
8337)
8.77259 (7121 to 7396)17.57846 (7709 to
7984)
Seattle
21.78506 (8364 to 8647)30.19091 (8949 to
9232)
16.28118 (7982 to 8254)22.78575 (8440 to
8711)
Minneapolis
−7.88578 (8461 to 8694)−18.37599 (7483 to
7715)
−2.19105 (8993 to 9216)−10.38340 (8228 to
8451)
Manhattan
15.511 050 (10 954 to
11 147)
−3.89203 (9107 to
9300)
12.610 774 (10 681 to
10 867)
−2.59331 (9238 to
9423)
Los Angeles
−2.715 289 (15 131 to
15 448)
−15.413 283 (13 124 to
13 441)
0.615 803 (15 651 to
15 955)
−9.414 235 (14 083 to
14 387)
Miami
*Data are for 306 hospital referral regions aggregated into fifths according to mean number of visits by physician in last six months of life for deaths in 2006.
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Figures
Fig 1 Conceptual framework and study design
Fig 2 Effect of adjusting for visits by physicians on the ability of diagnosis frequency to explain variance in mortality across
306 US hospital referral regions, using three measures for frequency of diagnosis. Regression equation was unweighted
for hospital referral region sample size
Fig 3 Mortality rates for each US hospital referral region (n=306) according to method of adjustment
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